size: 24,897,080 (_dta has notes) --------------------------------------------------------------------------------------------------------------------------------------------------- storage display value variable name type format label variable label --------------------------------------------------------------------------------------------------------------------------------------------------- ingredient str233 %233s * Ingredient dfroute str55 %55s * Dosage Form; Route doseform str46 %46s Dosage Form. (from dfroute) route str44 %44s Route of Administration. (from dfroute) trade_name str88 %88s * Trade Name (Proprietary Name) applicant str20 %20s * Applicant strength str206 %206s * Strength appl_type str1 %9s * Application Type appl_no long %12.0g * Application Number product_no byte %8.0g * Product Number tecodestr str15 %15s Therapeutic Equivalence (TE) Code tecode float %140.0g tecode * Therapeutic Equivalence (TE) Code appdatestr str29 %29s Approval Date appdate float %td appdate * Approval Date; 1982-01-01 = 'Approved Prior to Jan 1, 1982' rld str3 %9s * Reference Listed Drug type str5 %9s * Type appfull str87 %87s * Applicant Full Name * indicated variables have notes --------------------------------------------------------------------------------------------------------------------------------------------------- Sorted by: ingredient dfroute doseform route trade_name applicant strength appl_type appl_no product_no tecodestr tecode appdatestr a > ppdate rld type appfull _dta: 1. by Jean Roth , jroth@nber.org , 30 Sep 2014 ingredient: 1. The active ingredient(s) for the product. 2. Multiple ingredients are in alphabetical order, separated by a semicolon. dfroute: 1. Dosage form;Route of Administration 2. The product dosage form and route separated by a semi-colon. The format is not all uppercase. trade_name: 1. The trade name of the product as shown on the labeling. applicant: 1. The firm name holding legal responsibility for the new drug application. 2. The firm name is condensed to a maximum twenty character unique string. strength: 1. The potency of the active ingredient. May repeat for multiple part products. appl_type: 1. New Drug Application Type The type of new drug application approval. 2. New Drug Applications (NDA or innovator) are "N". Abbreviated New Drug Applications (ANDA or generic) are "A". appl_no: 1. New Drug Application (NDA) Number The FDA assigned number to the application. Format is nnnnnn. product_no: 1. Product Number. The FDA assigned number to identify the application products. 2. Each strength is a separate product. May repeat for multiple part products. Format is nnn. tecode: 1. Therapeutic Equivalence (TE) Code 2. The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. appdate: 1. Approval Date. The date the product was approved as stated in the FDA approval letter to the applicant. 2. The format is Mmm dd, yyyy. 3. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". rld: 1. Reference Listed Drug (RLD). The pioneer or innovator of the drug. 2. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. type: 1. The group or category of approved drugs. Format is RX, OTC, DISCN. appfull: